middle.news
Acrux Advances with New Ointment Launch and $3.99M Capital Raise
8:41am on Thursday 30th of January, 2025 AEDT
•
Pharmaceuticals
Read Story
Acrux Advances with New Ointment Launch and $3.99M Capital Raise
8:41am on Thursday 30th of January, 2025 AEDT
Key Points
Nitroglycerin 0.4% Ointment approved and launched in December 2024
Dapsone 7.5% Gel manufacturing underway; Dapsone 5% Gel pack size extended
Capital raising of $3.99 million completed via Placement and Share Purchase Plan
Positive operating cash flow of $0.775 million reported for the quarter
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE